BlueCrest Capital Management’s CVS Health CVS Stock Holding History

BlueCrest Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,498	Closed	-$258K	–	285
2021 Q4	$258K	Buy	+2,498	New	+$231K	0.01%	275
2019 Q2	–	Sell	-50,301	Closed	-$2.71M	–	557
2019 Q1	$2.71M	Buy	+50,301	New	+$3.1M	0.11%	145
2018 Q4	–	Sell	-38,152	Closed	-$3M	–	976
2018 Q3	$3M	Buy	38,152 +22,463	+143%	+$1.61M	0.08%	173
2018 Q2	$1.01M	Buy	+15,689	New	+$1.03M	0.03%	524
2017 Q3	–	Sell	-41,694	Closed	-$3.35M	–	885
2017 Q2	$3.35M	Buy	+41,694	New	+$3.29M	0.13%	218
2017 Q1	–	Sell	-17,268	Closed	-$1.36M	–	780
2016 Q4	$1.36M	Sell	17,268 -66,106	-79%	-$5.35M	0.07%	317
2016 Q3	$7.42M	Buy	83,374 +56,283	+208%	+$5.31M	0.23%	96
2016 Q2	$2.59M	Buy	27,091 +10,153	+60%	+$1.01M	0.11%	201
2016 Q1	$1.76M	Buy	16,938 +13,130	+345%	+$1.28M	0.11%	261
2015 Q4	$372K	Sell	3,808 -1,750	-31%	-$171K	0.02%	669
2015 Q3	$536K	Buy	+5,558	New	+$584K	0.02%	576
2015 Q2	–	Sell	-2,843	Closed	-$293K	–	812
2015 Q1	$293K	Buy	+2,843	New	+$288K	0.02%	527

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlueCrest Capital Management's CVS Position: Q1 2022 in Review

BlueCrest Capital Management sold out of CVS Health (CVS) in Q1 2022, closing a stake of 2,498 shares — an estimated $258K sold.

BlueCrest Capital Management first reported a position in CVS in Q1 2015 and held it in 12 quarters. The position peaked at $7.42M in Q3 2016. 2,365 funds tracked by Wall St. Rank hold CVS as of Q1 2022.

BlueCrest Capital Management reported no remaining CVS Health position as of Q1 2022 after selling out during the quarter.
BlueCrest Capital Management sold 2,498 CVS Health shares in Q1 2022, an estimated $258K.
BlueCrest Capital Management first reported a position in CVS Health in Q1 2015 and held it in 12 quarters.
BlueCrest Capital Management's CVS Health position peaked at $7.42M in Q3 2016.
2,365 funds tracked by Wall St. Rank held CVS Health as of Q1 2022.

Based on BlueCrest Capital Management's 13F filing for Q1 2022, filed 16 May 2022.